Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Prevalence of overweight and metabolic syndrome, and associated sociodemographic factors among adult Ecuadorian populations: the ENSANUT-ECU study.

Journal of endocrinological investigation·2020
Same author

Genetic and environmental influences on circulating NK and T cells and their relation to bipolar disorder.

International journal of bipolar disorders·2019
Same author

[The dysregulated brain - Consequences of spatial and temporal brain complexity for bipolar disorder pathophysiology and diagnosis].

Tijdschrift voor psychiatrie·2018
Same author

Th17/T regulator cell balance and NK cell numbers in relation to psychosis liability and social stress reactivity.

Brain, behavior, and immunity·2018
Same author

Immune dysregulation in offspring of a bipolar parent. Altered serum levels of immune growth factors at adolescent age.

Brain, behavior, and immunity·2017
Same author

The seroprevalence of antithyroid peroxidase antibodies in bipolar families and bipolar twins: results from two longitudinal studies.

International journal of bipolar disorders·2017

関連する実験動画

Updated: Jun 25, 2026

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
07:45

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor

Published on: June 27, 2011

GM-CSFの治療中に逆戻り可能な甲状腺機能障害.

K Hoekman1, B M von Blomberg-van der Flier, J Wagstaff

  • 1Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.

Lancet (London, England)
|August 31, 1991
PubMed
まとめ

グラヌロサイト・マクロファージ・コロニー刺激因子 (GM-CSF) は,既存の甲状腺抗体を有する患者の甲状腺機能不全を引き起こす可能性があります. この効果は一時的であり,GM-CSFの治療を中止した後に消滅した.

科学分野:

  • 腫瘍学 腫瘍学
  • 免疫学 免疫学とは
  • エンドクリノロジー エンドクリノロジー

背景:

  • 甲状腺抗原に対する自己免疫は,がん治療を複雑にすることがあります.
  • グラヌロサイト・マクロファージ・コロニー刺激因子 (GM-CSF) は,がん治療に使用されています.
  • 甲状腺自身免疫に対するGM-CSFの影響は,調査が必要です.

研究 の 目的:

  • GM-CSFが甲状腺自身免疫を誘発または悪化させるかどうかを判断する.
  • GM-CSF治療中に甲状腺機能と自己抗体状態を評価するために.

主な方法:

  • 14人の進行した乳がんと11人の軟組織肉腫の患者を研究した.
  • ドクソルビシン,サイクロフォスファミド,GM-CSFを静脈内投与した.
  • 治療前と治療中の甲状腺機能と自己抗体のモニタリング.

主要な成果:

  • 既存の甲状腺抗体を有する2人の患者は,一時的な甲状腺機能障害を発症した.
  • 甲状腺機能障害は,GM-CSFの停止後に解決しました.
  • 新しい自己免疫異常は観察されなかった.

さらに関連する動画

Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis
09:20

Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis

Published on: December 21, 2013

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

関連する実験動画

Last Updated: Jun 25, 2026

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
07:45

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor

Published on: June 27, 2011

Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis
09:20

Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis

Published on: December 21, 2013

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

結論:

  • GM-CSFは,感受性の高い個体において,甲状腺自身免疫を一時的に悪化させる可能性があります.
  • GM-CSFによる抗原呈現細胞刺激は,この現象を説明できる.
  • GM-CSFの免疫調節効果を理解するためにさらなる研究が必要です.